Birdwatch Note Rating
2024-05-01 12:01:22 UTC - NOT_HELPFUL
Rated by Participant: A9C7ABD6B1650041376378892C6D80BD4204DFB85D75EF9620AD9222BBE9013D
Participant Details
Original Note:
EBC-46 is a compound with potential anti-cancer properties that has been successfully used in veterinary medicine and is currently being studied for use in humans. However, the claim of it killing cancer in 48 hours should be viewed in the context of ongoing research. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268252/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182759/ https://www.europeanpharmaceuticalreview.com/news/175005/novel-cancer-therapeutic-synthesised-by-stanford-researchers/
All Note Details